ArticleThe Lancet regional health. Europe2025

Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (The ANTIBIO-STA study): a randomised, controlled, open-label trial.

Alexandre Sabaté-Elabbadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.